Are you Dr. Goldberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Sacramento, CA 95817Phone+1 916-734-8252
Summary
- Dr. Zelanna Goldberg, MD is a radiation oncologist in Sacramento, California. She is currently licensed to practice medicine in California.
Education & Training
University of Toronto Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1998 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- 26 citationsUse of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation ...Chunhui Luo, Claus Chunli Yang, Samir Narayan, Robin L Stern, Julian R Perks
International Journal of Radiation Oncology, Biology, Physics. 2006-11-15 - 116 citationsRadiation-induced effects in unirradiated cells: a review and implications in cancer.Zelanna Goldberg, Bruce E. Lehnert
International Journal of Oncology. 2002-08-01 - 98 citationsDacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A. Jänne, Sai-Hong Ignatius Ou, Dong Wan Kim, Geoffrey R. Oxnard, Renato G. Martins
The Lancet. Oncology. 2014-12-01
Press Mentions
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsAugust 10th, 2021- Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. As Chief Medical OfficerJune 2nd, 2021
